Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
2,001 to 2,020 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Alphaherpesvirus US3 protein-mediated inhibition of the m6A mRNA methyltransferase complex. | Cell Rep | 2022 | 35858564 | PubTator, text mining | PubMed |
| Enzymes flying under the radar: Cryptic METTL3 can persist in knockout cells. | PLoS Biol | 2022 | 35857761 | PubTator, text mining | PubMed |
| Functions and mechanisms of N6‑methyladenosine in prostate cancer (Review). | Mol Med Rep | 2022 | 35856412 | PubTator, text mining | PubMed |
| Inhibitory immune checkpoints cause exhaustion of viral immunity in coronary artery disease. | Nat Cardiovasc Res | 2022 | 35856084 | PubTator, text mining | PubMed |
| Alternative splicing of METTL3 explains apparently METTL3-independent m6A modifications in mRNA. | PLoS Biol | 2022 | 35853000 | PubTator, text mining | PubMed |
| N6-methyladenosine modification-mediated mRNA metabolism is essential for human pancreatic lineage specification and islet organogenesis. | Nat Commun | 2022 | 35851388 | PubTator, text mining | PubMed |
| The role of N6-methyladenosine-modified non-coding RNAs in the pathological process of human cancer. | Cell Death Discov | 2022 | 35851061 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Regulatory Networks of m6A Regulators and Reveals Prognosis Biomarkers in Sarcoma. | Front Oncol | 2022 | 35847857 | PubTator, text mining | PubMed |
| Regulatory Role of N6-Methyladenosine (m6A) Modification in Osteoarthritis. | Front Cell Dev Biol | 2022 | 35846376 | PubTator, text mining | PubMed |
| Sevoflurane Inhibits lncRNA HOTAIR-Modulated Stability of HK2 mRNA in a m6A-Dependent Manner to Dampen Aerobic Glycolysis and Proliferation in Lung Cancer. | Biomed Res Int | 2022 | 35845960 | PubTator, text mining | PubMed |
| Human Umbilical Cord Mesenchymal Stem Cells Improve Premature Ovarian Failure through Cell Apoptosis of miR-100-5p/NOX4/NLRP3. | Biomed Res Int | 2022 | 35845923 | PubTator, text mining | PubMed |
| DDX5: an expectable treater for viral infection- a literature review. | Ann Transl Med | 2022 | 35845539 | PubTator, text mining | PubMed |
| Targeting Ferroptosis as a Novel Approach to Alleviate Aortic Dissection. | Int J Biol Sci | 2022 | 35844806 | PubTator, text mining | PubMed |
| Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance. | Mol Cancer | 2022 | 35843942 | PubTator, text mining | PubMed |
| Roles of circRNAs in hematological malignancies. | Biomark Res | 2022 | 35840998 | PubTator, text mining | PubMed |
| Control of animal virus replication by RNA adenosine methylation. | Adv Virus Res | 2022 | 35840182 | PubTator, text mining | PubMed |
| Research advances of N6-methyladenosine in diagnosis and therapy of pancreatic cancer. | J Clin Lab Anal | 2022 | 35837987 | PubTator, text mining | PubMed |
| Crosstalk of RNA Adenosine Modification-Related Subtypes, Establishment of a Prognostic Model, and Immune Infiltration Characteristics in Ovarian Cancer. | Front Immunol | 2022 | 35837397 | PubTator, text mining | PubMed |
| m6A Methylation in Cardiovascular Diseases: From Mechanisms to Therapeutic Potential. | Front Genet | 2022 | 35836571 | PubTator, text mining | PubMed |
| N6-methyladenosine methylation related immune biomarkers correlates with clinicopathological characteristics and prognosis in clear cell renal cell carcinoma. | Transl Cancer Res | 2022 | 35836532 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=101